Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma.
Saved in:
| Title: | Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma. |
|---|---|
| Authors: | Fujiwara Y; Department of Hematology, Nippon Medical School, Tokyo, JPN.; Department of Hematology, Shonantobu General Hospital, Chigasaki, JPN., Takaono A; Department of Internal Medicine, Shonantobu General Hospital, Chigasaki, JPN., Kitagawa A; Department of Nephrology, Shonantobu General Hospital, Chigasaki, JPN., Okamoto M; Department of Hematology, Shonantobu General Hospital, Chigasaki, JPN. |
| Source: | Cureus [Cureus] 2026 Jan 03; Vol. 18 (1), pp. e100718. Date of Electronic Publication: 2026 Jan 03 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
